🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib, open-label, multiple-center, multiple-dose study design...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01546519
Treatments Being Tested
This multicenter, non-randomized, open-label study will evaluate the effica...
Status
Completed
Location
Western Regional Medical Center at Cancer Treatment Centers of America
Start Date
2014-04-14
Trial ID
NCT02091141
Treatments Being Tested
The primary objectives are to: 1. Evaluate the safety and tolerability of ...
Status
Completed
Location
Central Brisbane Dermatology
Start Date
2020-07-16
Trial ID
NCT04416516
Treatments Being Tested
The purpose of this study is to evaluate the safety of vismodegib in combin...
Status
Terminated
Location
CHU La Timone
Start Date
2012-06
Trial ID
NCT01601184
Treatments Being Tested
The purpose of this study is to evaluate and compare the safety and efficac...
Status
Completed
Location
Children's Hospital Oakland Research Institiute
Start Date
2012-04
Trial ID
NCT01556009
Treatments Being Tested
The purpose of this study is to investigate the safety and effectiveness of...
Status
Completed
Location
Saint Louis University Department of Dermatology
Start Date
2013-01-14
Trial ID
NCT01700049
Treatments Being Tested
The purpose of this study is to reduce the number of new surgically eligibl...
Status
Completed
Location
Children's Hospital Oakland Research Institiute
Start Date
2009-08
Trial ID
NCT00957229
Treatments Being Tested
This is a Phase II, single-arm, two-cohort multicenter clinical trial evalu...
Status
Completed
Location
Mayo Clinic
Start Date
2009-02-10
Trial ID
NCT00833417
Treatments Being Tested
This randomized, double-blind, regimen-controlled, phase II, multicenter st...
Status
Completed
Location
Dermatology Research Associate
Start Date
2013-04-30
Trial ID
NCT01815840
Treatments Being Tested
The objective of N²M² is the improvement of overall survival of patients wi...
Status
Completed
Location
Charité Berlin, Neurosurgery
Start Date
2018-05-07
Trial ID
NCT03158389
Treatments Being Tested